Publications

121. Performance Enhancing Asymmetric Catalysis (PEAC) Unlocks Tuning Without Rebuilding Zihang Deng, Jeffrey N. Johnston* Chem Catal. 2025, 5, 101577


120. Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from an RyR2 inhibitor to RyR2 activator Tri Q. Do#, Daniel J. Blackwell#, Abigail N. Smith, Madelaine P. Thorpe, Robyn T. Rebbeck, Derek R. Laver, Jeffrey N. Johnston, and Björn C. Knollmann* Mol. Pharm. 2025, 107, 100086


1119. Total Synthesis of Feglymycin Using Umpolung Amide Synthesis Preston C. Gourville, Jade A. Bing, Rashanique D. Quarels, Sergey V. Tsukanov, Kenneth E. Schwieter, Kazuyuki Tokumaru, Amanda B. Stephens, Dawn M. Makley, Bo Shen, Abigail N. Smith, Jeffrey N. Johnston* Angew. Chem. Int. Ed. Engl. 2025, 64, e202508819


118.Performance Enhancing Asymmetric Catalysis Driven by Achiral Counterion Design Zihang Deng, Jenna L. Payne, Mahesh Vishe, Julius E. L. Jan, Cody M. Funk, Jeffrey N. Johnston* J. Am. Chem. Soc. 2025, 147, 17584-17591

Highlighted by Dirk Trauner & Michael D. Zott in Synfacts


117.End-to-End Backbone Cyclization Enhances Passive Permeability of bRo5 Oligomeric Depsipeptides with Nonlinear Size Dependence Madelaine Thorpe, Corey R. Hopkins, Jeffrey N. Johnston* ACS Med. Chem. Lett. 2025 16, 638-645


116.Elucidating Fluorine Steering Effects in Diels-Alder Reactions Interfaced with Charge-Enhanced Reactivity Sabrina Hoford, Julius E. L. Jan, Jeffrey N. Johnston,* Travis Dudding* Eur. J. Org. Chem. 2025, e202401203


115. The Backbone Constitution Drives Passive Permeability Independent of Side Chains in Depsipeptide and Peptide Macrocycles
Madelaine P. Thorpe, Abigail N. Smith, Daniel J. Blackwell, Corey R. Hopkins, Bjorn C. Knollmann, Wendell S. Akers, and Jeffrey N. Johnston*
Chem. Sci. 2024, 15, 14977-14987


114. Backbone-Determined Antiarrhythmic Structure-Activity Relationships for a Mirror-Image, Oligomeric Depsipeptide Natural Product
Madelaine P. Thorpe, Daniel J. Blackwell, Bjorn C. Knollmann, and Jeffrey N. Johnston*
J. Med. Chem. 2024, 67, 12205-12220

Special issue for Natural Products Driven Medicinal Chemistry


113.Generality-Driven Catalyst Development: A Universal Catalyst for Enantioselective Nitroalkene Reduction
Zihang Deng, Melanie A. Padalino, Julius E. L. Jan, Sangjun Park, Michael W. Danneman, and Jeffrey N. Johnston*
J. Am. Chem. Soc. 2024, 146, 1269-1275

Highlighted by Winter et al. in Trendbericht: Organische Chemie 2025

Highlighted by Douglass Taber at Organic Chemistry Highlights

Highlighted by Reto Mueller at the Organic Chemistry Portal


112.ent-Verticilide B1 inhibits type 2 ryanodine receptor channels and is antiarrhythmic in Casq2-/- mice
Gochman, A.; Do, T. Q.; Kim, K.; Schwarz, J. A.; Thorpe, M. P.; Blackwell, D. J.; Ritschel, P.; Smith, A. N.; Rebbeck, R. T.; Akers, W. S.; Cornea, R. L.; Laver, D. R.; Johnston, J. N.; Knollmann, B. C.* bioRxiv2023 & Mol. Pharm. 2024, 105, 194-201


111. RyR2 Binding of an Antiarrhythmic Cyclic Depsipeptide Mapped Using Confocal Fluorescence Lifetime Detection of FRET
Šeflová, J.; Schwarz, J. A.; Smith, A. N.; Svensson, B.; Blackwell, D. J.; Phillips, T. A.; Nikolaienko, R.; Bovo, E.; Rebbeck, R. T.; Zima, A. V.; Thomas, D. D.; Van Petegem, F.; Knollmann, B. C.; Johnston, J. N.*; Robia, S. L.; Cornea, R. L.*
ACS Chem. Biol.
2023, 18, 2290-2299.


110.The selective RyR2 inhibitor ent-verticilide suppresses atrial fibrillation susceptibility caused by Pitx2 deficiency
Kim, K. ; Blackwell, D.J. ; Yuen, S.L. ; Thorpe, M. P. ; Johnston, J. N. ; Cornea, R.L. ; Knollmann, B. C.*
J. Mol. Cell. Cardiol. 2023, 180, 1-9
“Top Original Research Paper of the Year” by the Editors of the J. Mol. Cell. Cardiol. for 2023
Highlighted by Leigh MacMillan in a VUMC Reporter spotlight


109. In vivo pharmacokinetic and pharmacodynamic properties of the antiarrhythmic molecule ent-verticilide
Blackwel, D.; Smith, A.; , Do, T. Q.; Gochman, A.; Schmeckpeper, J.; Hopkins, C.; Akers, W.*; Johnston, J. N.*; Knollmann, B.*
J. Pharm. Exptl. Ther. 2023, 385, 205-213




106. Structure-Activity Relationships for the N-Me- versus N-H-Amide Modification to Macrocyclic ent-Verticilide Antiarrhythmics
Smith, A.; Thorpe, M; Blackwell, D; Batiste, S; Hopkins, C; Schley, N; Knollmann, B; Johnston, J. N. ACS Med. Chem. Lett. 2022, 13, 1755-1762.

Featured in the Virtual Collection - Future of Medicinal Chemistry Collection

Don’t miss the Editorial, including statements from Abby (and Jeff) - Special Collection Editorial


105. Preparation of N-Aryl Amides by Epimerization-Free Umpolung Amide Synthesis Crocker, M. S.; Deng, Z. Johnston, J. N. J. Am. Chem. Soc. 2022, 144, 16708-16714.
Featured by Douglass Taber in Org. Chem. Highlights - spectacular reactions


104. Enantioselective Iodolactonization to Prepare ε-Lactone Rings Using Hypervalent Iodine Payne, J.; Deng, Z.; Flach, A.; Johnston, J. N.* [†equal contribution] Chem. Sci. 2022, 13, 7318-7324.


103. Resolving Bromonitromethane Sourcing by Synthesis: Preparation at the Decagram Scale Thorpe, M. P.; Smith, A. N.; Crocker, M. S.;Johnston,
J. N. J. Org. Chem. 2022, 87, 5451-5455.


102. Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2 Deficient Hearts
van Opbergen, C.; Bagwan, N.; Maurya, S; Kim, J.C.; Smith, A; Blackwell, D; Johnston, J.N.; Knollmann, B; Cerrone, M.; Lundby, A; Delmar, M.
Circulation 2022, 145, 1480-1496.
Highlighted in Muscle Cell News


101. Fluorine-Induced Diastereodivergence Discovered in an Equally Rare Enantioselective syn-aza-Henry Reaction
Bing, J. A.; Schley, N. D.; Johnston, J. N. Chem. Sci. 2022, 13, 2614-2623.


100. Ring-Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity
Smith, A. N.; Blackwell, D. J.; Knollmann, B. C.; Johnston, J. N.
ACS Med. Chem. Lett. 2021, 12, 1942-1947.


99. DFT-Based Stereochemical Rationales for the Bifunctional Brønsted Acid/Base-Catalyzed Diastereodivergent and Enantioselective aza-Henry Reactions of α-Nitro Esters Struble, T. J.;† Foy, Hayden;† Dudding, T.*; Johnston, J.N. [†equal contribution] J. Org. Chem. 2021, 86, 15606-15617.


98. The Formation of Impossible Rings in Macrocyclooligomerizations for Cyclodepsipeptide Synthesis: The 18-From-12 Paradox
Smith, A. N.; Johnston, J. N. J. Org. Chem. 2021, 86, 7904-7919.
Related: Batiste, S. M.; Johnston, J. N., Correction to “Evidence for Ion-Templation During Macrocyclooligomerization of Depsipeptides”. J. Am. Chem. Soc. 2021, 143, 6701.
Related: Correction to “Rapid synthesis of cyclic oligomeric depsipeptides with positional, stereochemical, and macrocycle size distribution control”
here.


97. RYR2 Channel Inhibition is the Principal Mechanism of Flecainide Action in CPVT
Kryshtal, D. O.; Blackwell, D. J.; Egly, C. L.; Smith, A. N.; Batiste, S. M.; Johnston, J. N.; Laver, D. R.; Knollmann, B. C. Circ. Res. 2021, 128, 321.